| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-13 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
4e-10 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-08 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-07 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-07 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.23 |
2e-06 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
6e-06 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-05 |